<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H5902804FF7B948C0882071E8543911FA" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 HR 2148 IH: Synthetics are Dangerous Act of 2013</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2013-05-23</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 2148</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130523">May 23, 2013</action-date>
			<action-desc><sponsor name-id="C001072">Mr. Carson of Indiana</sponsor>
			 introduced the following bill; which was referred to the
			 <committee-name committee-id="HIF00">Committee on Energy and
			 Commerce</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Office of National Drug Control Policy
		  Reauthorization Act of 1998 to increase public awareness about the dangers of
		  synthetic drugs through the national youth antidrug media
		  campaign.</official-title>
	</form>
	<legis-body id="H3993B9285B11413FB34772DDE6447A76" style="OLC">
		<section id="H7FE5DC9C838E418D92D73F6559AD6940" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>Synthetics are Dangerous Act of
			 2013</short-title></quote>.</text>
		</section><section id="H46F538E607C14239BF89B36AC4B1FAA8"><enum>2.</enum><header>Findings</header><text display-inline="no-display-inline">The Congress finds as follows:</text>
			<paragraph id="HD60D6C6A77984579A7BF83EE875AD6AB"><enum>(1)</enum><text>Synthetic drugs,
			 sometimes referred to as designer drugs, are chemical compounds produced in
			 clandestine laboratories to mimic or enhance the effects of schedule I
			 controlled substances such as methamphetamine, ecstasy, and marijuana.</text>
			</paragraph><paragraph id="HCDD81A0529B14AF69F9058E653E7A242"><enum>(2)</enum><text>Given the lack of
			 extensive medical research on many synthetic drugs and their various analogues,
			 the full scope of their harmful effects is not well understood.</text>
			</paragraph><paragraph id="H2DD4ABE460E345B49D8710D93C99D0B4"><enum>(3)</enum><text>The circumstantial
			 evidence of the harmful effects of synthetic drugs, particularly synthetic
			 cannabinoids (such as <quote>K2</quote> and <quote>spice</quote>) and synthetic
			 stimulants (such as <quote>bath salts</quote>) are, nevertheless,
			 alarming—</text>
				<subparagraph id="H6949568A72D847E48397B25291A9C009"><enum>(A)</enum><text>in 2010, more than
			 11,000 individuals were admitted into the emergency room from complications
			 arising from synthetic drug use, and nearly 25 percent of those patients
			 required further medical treatment; and</text>
				</subparagraph><subparagraph id="H513E062DDAC34E4FB96D8C4747C056D4"><enum>(B)</enum><text>in 2011, the
			 American Association of Poison Control Centers reported more than a two-fold
			 increase in the number of calls related to synthetic marijuana from the
			 previous year.</text>
				</subparagraph></paragraph><paragraph id="H0777CB3AA7FD4D35B5F993FFAC146F8F"><enum>(4)</enum><text>The harmful
			 effects of ingesting synthetic drugs include but are not limited to agitation,
			 anxiety, nausea, vomiting, tachycardia, elevated blood pressure, tremor,
			 seizures, hallucinations, paranoid behavior, and nonresponsiveness.</text>
			</paragraph><paragraph id="HF22CAB7F6B2B465198CB99A2A66E15DF"><enum>(5)</enum><text>Like all schedule
			 I drugs, these synthetic drugs are drugs that have a high potential for abuse,
			 have no medical use in the United States, and lack an accepted safe use.</text>
			</paragraph><paragraph id="HB3B44734B95E45C6B54C51A22C1BFC3D"><enum>(6)</enum><text>The passage of the
			 Synthetic Drug Abuse Prevention Act of 2012 was an important step in reducing
			 the access of teens and young adults to dangerous and addictive synthetic
			 drugs.</text>
			</paragraph><paragraph id="H572E4F19E87F4CF6A8BF2B91C8D330C7"><enum>(7)</enum><text>New synthetic
			 drugs are being manufactured that contain chemical compounds not found on
			 schedule I, as set forth in section 202(c) of the Controlled Substances Act (21
			 U.S.C. 812(c)), that nevertheless mimic or enhance the effects of controlled
			 substances like methamphetamine, marijuana, ecstasy, and LSD.</text>
			</paragraph><paragraph id="H23361BD21F094B3CACE2B388E6F2DB67"><enum>(8)</enum><text>Hundreds,
			 potentially thousands, of teens and young adults will be admitted into
			 emergency rooms around the country from complications caused by the ingestion
			 of the next breed of harmful, synthetic drugs.</text>
			</paragraph><paragraph id="HC1B5CE3367894D1483ABF687C1D4A353"><enum>(9)</enum><text>It is the sense of
			 the Congress that there is an urgent need, particularly among teens, young
			 adults, and parents, to raise awareness about the dangers of these new
			 synthetic drugs.</text>
			</paragraph></section><section id="HBB8C0E79740F499394DEC98937906F15"><enum>3.</enum><header>Increasing public
			 awareness of dangers of synthetic drugs through national youth antidrug media
			 campaign</header><text display-inline="no-display-inline">Section 709 of the
			 Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C.
			 1708) is amended—</text>
			<paragraph id="HB7AFA00A59A4417395A1E4F693DE2C83"><enum>(1)</enum><text>in subsection
			 (a)(3), by inserting <quote>and synthetic drug use</quote> after <quote>illegal
			 drug use</quote>; and</text>
			</paragraph><paragraph id="HC140AFCA6EB34DA9A2CC16D1710DD432"><enum>(2)</enum><text>by redesignating
			 subsection (l) as subsection (m) and inserting after subsection (k) the
			 following new subsection:</text>
				<quoted-block id="H4BBB8A8379864E069B08BC3943970BDB" style="OLC">
					<subsection id="H19F2D9F29CD94B308CCAB5815E085F0E"><enum>(l)</enum><header>Definitions</header><text>For
				purposes of this section:</text>
						<paragraph id="H1C78056CC190441FB248DABC90D4286F"><enum>(1)</enum><header>Drug</header><text>The
				term <quote>drug</quote> has the meaning given such term in section 702(3) and
				includes a synthetic drug.</text>
						</paragraph><paragraph id="HD4145B1D96154FF3B2C519B65FF0BD62"><enum>(2)</enum><header>Synthetic
				drug</header><text>The term <quote>synthetic drug</quote> means an artificially
				produced substance that, as determined by the Director, is an analog or
				derivative of a controlled substance (as defined in section 102(6) of the
				Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/802">21 U.S.C. 802(6)</external-xref>), but is not itself a controlled
				substance.</text>
						</paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
			</paragraph></section></legis-body>
</bill>


